Clinical trial / 2015
Low-dose creatine supplementation for one year did not alter bone or muscle outcomes.
Postmenopausal osteopenic women were randomized to receive 1 g/d of creatine (n = 56) or dextrose placebo (n = 53) for one year. Bone mineral density at the spine, hip sites, and total skeleton showed no significant differences between or within treatment arms. Similarly, creatine did not significantly change body composition, lean mass, timed-up-and-go performance, or timed-stands test scores.
- Study type
- Randomized controlled trial
- Who was studied
- 109 postmenopausal osteopenic women, Sao Paulo, Brazil
- What was measured
- Bone mineral density, body composition, muscle function
THE PAPER
Effects of long-term low-dose dietary creatine supplementation in older women.
Lobo DM, Tritto AC, da Silva LR, de Oliveira PB, Benatti FB, Roschel H, Nieß B, Gualano B, Pereira RM. Exp Gerontol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.